David J Waxman Selected Research

David J Waxman Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 01/2002
8	Glioma (Gliomas) 01/2020 - 06/2014
7	Gliosarcoma 02/2013 - 01/2003
6	Hypersensitivity (Allergy) 01/2018 - 12/2010
5	Brain Neoplasms (Brain Tumor) 05/2015 - 03/2012
4	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2006
4	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 07/2004
4	Hypoxia (Hypoxemia) 05/2015 - 08/2005
4	Prostatic Neoplasms (Prostate Cancer) 11/2011 - 01/2009
3	Feminization 01/2022 - 01/2016
3	Inflammation (Inflammations) 11/2020 - 12/2010
3	Liver Neoplasms (Liver Cancer) 01/2016 - 07/2002
2	Liver Diseases (Liver Disease) 01/2022 - 01/2016
2	Disease Susceptibility (Diathesis) 01/2020 - 11/2015
2	Carcinogenesis 06/2019 - 03/2007
2	Obesity 01/2019 - 01/2016
2	Melanoma (Melanoma, Malignant) 11/2016 - 04/2016
2	Infections 01/2016 - 12/2008
2	Neoplasm Metastasis (Metastasis) 04/2013 - 04/2010
2	Starvation 01/2009 - 12/2008
1	Fibrosis (Cirrhosis) 01/2020
1	Insulin Resistance 01/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2016
1	Carcinoma (Carcinomatosis) 11/2016

Drug/Important Bio-Agent (IBA)

28	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2002
25	Pharmaceutical PreparationsIBA 01/2021 - 01/2002
18	ProdrugsIBA 01/2014 - 01/2002
12	EnzymesIBA 01/2017 - 01/2002
11	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2011 - 01/2002
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2003
7	ChromatinIBA 01/2022 - 01/2011
7	Angiogenesis InhibitorsIBA 01/2021 - 11/2007
7	CytochromesIBA 09/2010 - 01/2003
6	Deoxyribonucleases (DNase)FDA Link 01/2018 - 12/2010
6	Ifosfamide FDA LinkGeneric 02/2007 - 01/2002
5	Growth Hormone (Somatotropin)IBA 01/2019 - 12/2010
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2014 - 01/2009
4	Axitinib (AG 013736)IBA 05/2013 - 01/2008
3	Therapeutic UsesIBA 01/2022 - 01/2002
3	XenobioticsIBA 06/2019 - 01/2016
3	CytokinesIBA 11/2016 - 03/2012
3	LipidsIBA 01/2016 - 01/2011
3	PPAR alphaIBA 01/2016 - 07/2002
3	ChemokinesIBA 05/2015 - 03/2012
3	Cytochrome P-450 CYP2B1 (PROD)IBA 12/2010 - 09/2005
3	CaspasesIBA 09/2010 - 12/2002
3	Oxidoreductases (Dehydrogenase)IBA 03/2006 - 01/2002
3	Cytochrome P-450 CYP3AIBA 09/2005 - 01/2003
3	AnthracyclinesIBA 08/2005 - 01/2003
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	InterferonsIBA 01/2020 - 05/2015
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2019 - 07/2002
2	Insulin (Novolin)FDA Link 01/2019 - 09/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2018 - 09/2010
2	1,4- bis(2- (3,5- dichloropyridyloxy))benzeneIBA 01/2018 - 01/2017
2	PPAR gammaIBA 01/2016 - 09/2008
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 03/2010
2	Complement System Proteins (Complement)IBA 05/2015 - 12/2010
2	Sorafenib (BAY 43-9006)FDA Link 06/2014 - 05/2013
2	Oxygen (Dioxygen)IBA 05/2013 - 04/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2013 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 12/2008
2	Tyrosine Kinase InhibitorsIBA 04/2011 - 01/2009
2	4-hydroxycyclophosphamideIBA 04/2011 - 01/2009
2	methyl cellosolve (ethylene glycol monomethyl ether)IBA 03/2011 - 06/2010
2	methoxyacetic acidIBA 03/2011 - 06/2010
2	Biological ProductsIBA 01/2011 - 04/2010
2	AndrogensIBA 12/2010 - 04/2010
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 09/2010 - 09/2005
2	Glutathione (Reduced Glutathione)IBA 08/2005 - 12/2002
2	methoxy-morpholinyl-doxorubicinIBA 01/2005 - 01/2003
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Contrast MediaIBA 01/2021
1	VaccinesIBA 01/2020
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Interferon Type IIBA 01/2020
1	SteroidsIBA 06/2019
1	STAT5 Transcription FactorIBA 01/2019
1	AdiponectinIBA 01/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2019
1	Insulin ReceptorIBA 01/2019
1	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Insulin Receptor Substrate ProteinsIBA 01/2019
1	Interleukin-15 (Interleukin 15)IBA 01/2019
1	Cytotoxins (Cytolysins)IBA 10/2018
1	Polystyrenes (Polystyrene)IBA 10/2018
1	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2018
1	Cyclin D1IBA 01/2017
1	Constitutive Androstane ReceptorIBA 01/2017
1	CateninsIBA 01/2017
1	Cytokine Receptors (Cytokine Receptor)IBA 11/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2016
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 11/2016
1	CpG ODN 1826IBA 04/2016

Therapy/Procedure

23	Therapeutics 01/2022 - 01/2002
16	Drug Therapy (Chemotherapy) 01/2022 - 12/2003
2	Caloric Restriction 11/2020 - 01/2016
1	Immunotherapy 04/2016